Childhood Absence Epilepsy: Brivaracetam Safety Study

We are studying the long-term safety of brivaracetam in children and young adults with childhood or juvenile absence epilepsy. This research aims to understand how well the medication is tolerated over time.

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Brivaracetam
Brivaracetam is a medicine used to help control seizures in people with epilepsy.

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Brivaracetam
Brivaracetam is a substance that helps control seizures in people with epilepsy by reducing abnormal electrical activity in the brain.

What similar medicines might you know?

Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.

Brivaracetam Anfarm
Brivaracetam Glenmark
Brivaracetam Sandoz

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...
Neurological Institute Foundation Casimiro Mondino
#40764: Neuropsichiatria Infantile
La Massimina-Casal Lumbroso, Italy
Azienda Ospedaliera Universitaria Gaetano Martino Messina
#40765: Dipartimento di Neuroscienze
Messina, Italy
ASST Fatebenefratelli Sacco
#40762: Pad B Reparto Neurologia Pediatrica
Milan, Italy

Sponsor: UCB Biopharma
Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.